An emulated clinical trial of deprescribing proton pump inhibitors in patients with cirrhosis.

Published in: The American journal of gastroenterology (2023)

PPI deprescribing has benefits but requires ongoing support and alternative therapies for gastrointestinal symptoms.

Keyphrases